Mitigare

Active Ingredient(s): Colchicine
FDA Approved: * September 26, 2014
Pharm Company: * HIKMA PHARMS LLC
Category: Gout

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Mitigare Overview

Colchicine (sold under brand names Colcrys or Mitigare) is a medication most commonly used to treat gout.[1][2][3] In addition to gout, colchicine is used to treat familial Mediterranean fever, pericarditis, and Behçet's disease.[2] Adverse effects are primarily gastrointestinal upset at high doses.[4] It is a toxic alkaloid and secondary metabolite, originally extracted from plants of the genus Colchicum (au...

Read more Mitigare Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Colchicine

Recent Mitigare Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Mitigare: (1 result)

Sorted by National Drug Code

• 59467-318 Mitigare .6 mg Oral Capsule by Hikma Americas, Inc.

Other drugs which contain Colchicine or a similar ingredient: (6 results)

• COLCHICINE 28 discussions
• COL-PROBENECID Colchicine + Probenecid1 discussion
• COLBENEMID Colchicine + Probenecid
• COLCHICINE + PROBENECID
• COLCRYS Colchicine2 discussions
• PROBEN-C Colchicine + Probenecid